Back to Search
JORDAN WEBER, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1629770680Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Unusual spinal arteriovenous dural fistula: digital subtraction and magnetic resonance angiography.
PMID 19636507·Klin Neuroradiol·2009
5-case
Photolytic degradation of methyl-parathion and fenitrothion in ice and water: implications for cold environments.
PMID 19540637·Environ Pollut·2009
8-other
The physiology of long-distance migration: extending the limits of endurance metabolism.
PMID 19218508·J Exp Biol·2009
7-preclinical
A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma.
PMID 19671877·Clin Cancer Res·2009
3-trial
The aqueous photodegradation of fenitrothion under various agricultural plastics: implications for pesticide longevity in agricultural 'micro-environments'.
PMID 19282019·Chemosphere·2009
8-other
A comparative study on the aqueous photodegradation of two organophosphorus pesticides under simulated and natural sunlight.
PMID 19280044·J Environ Monit·2009
4-observational
Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma.
PMID 19536884·Cancer·2009
3-trial
Ipilimumab: controversies in its development, utility and autoimmune adverse events.
PMID 19198837·Cancer Immunol Immunother·2009
6-review
Hyperalgesia induced by oral stavudine administration to rats does not depend on spinal neuronal cell death, or on spinal or systemic inflammatory cytokine secretion, or metabolic dysregulation.
PMID 19442827·Neurotoxicology·2009
7-preclinical
Overcoming immunologic tolerance to melanoma: targeting CTLA-4 with ipilimumab (MDX-010).
PMID 19001147·Oncologist·2008
6-review
Phase I/II study of ipilimumab for patients with metastatic melanoma.
PMID 19018089·J Clin Oncol·2008
3-trial
Tumor evasion may occur via expression of regulatory molecules: a case for CTLA-4 in melanoma.
PMID 18997841·J Invest Dermatol·2008
7-preclinical
Suckers or saviors? Consistent contributors in social dilemmas.
PMID 19025287·J Pers Soc Psychol·2008
8-other
Toward stable interfaces in conjugated polymers: microporous poly(p-phenylene) and poly(phenyleneethynylene) based on a spirobifluorene building block.
PMID 18433126·J Am Chem Soc·2008
8-other
Oral administration of stavudine induces hyperalgesia without affecting activity in rats.
PMID 17632188·Physiol Behav·2007
7-preclinical
Review: anti-CTLA-4 antibody ipilimumab: case studies of clinical response and immune-related adverse events.
PMID 17673617·Oncologist·2007
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 275 W MACARTHUR BLVD
OAKLAND, CA 94611 - Phone
- (510) 752-1000
Quick Facts
- NPI
- 1629770680
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile